Abcam PLC operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Abcam PLC with three other
pharmaceutical manufacturers in Europe:
Dechra Pharmaceuticals PLC
sales of £359.28 million [US$496.92 million]
of which 63%
was European Pharmaceuticals),
Dottikon ES Holding AG
(151.75 million Swiss Francs [US$157.09 million]
of which 89%
was Pharma Products), and
Allergy Therapeutics PLC
(£64.14 million [US$88.71 million]
of which 100%
Abcam PLC reported sales of £217.10 million (US$300.27 million)
June of 2017.
increase of 26.5%
versus 2016, when the company's sales were £171.67 million.
Sales at Abcam PLC have increased during each of the previous five years
(and since 2012, sales have increased a total of 122%).